Posted in M&A / Deals UCB cuts $1.15bn deal to buy epilepsy biotech Neurona April 20, 2026 Pharmaphorum UCB has dipped its toe into the M A waters once again with an agreement to buy US biotech Neurona and its cell therapy for a common form of epilepsy. M&A / DealsNeuroscienceRead full story